UPDATE: December 18, 2014 Sound Science of Redesigned STREAM Trial Investigators of the STREAM trial have successfully redesigned Stage 2 of the study to address concerns raised in the original article (below). Published in our Spring 2014 issue, this…
Tax dollars are making it easier for the drug and diagnostics industry to develop and market essential TB products. Is the public getting a fair return on its investment? By Lindsay McKenna Motivating the pharmaceutical industry to step up and…
After a study suggests that we’ve been using too high a dose of efavirenz for a decade and a half, the move toward scaling up a lower and more cost-effective one faces some hurdles By Tim Horn and Polly Clayden…
Advocates scramble to stay ahead of coverage rejections, formulary concerns, and exorbitant out-of-pocket expenses facing people living with HIV By Kenyon Farrow #GetCovered That’s the White House’s official hashtag and marketing campaign to spike the number of Americans enrolling into…
An Office of National AIDS Policy progress report obscures the state of the domestic U.S. HIV/AIDS response By Mark Harrington On World AIDS Day, December 1, 2013, the White House Office of National AIDS Policy (ONAP) issued a peppy and…
The CDC’s High-Impact Prevention strategy takes aim at the stubborn HIV incidence rate in the United States. The only problem: it doesn’t include an ambitious plan for those at risk for the virus By Jeremiah Johnson There is no shortage…
April 1. This is the day upon which we are reminded of what we are on the other three hundred and sixty-four. —Mark Twain, Pudd'nhead Wilson By Tim Horn We’re being duped by our government agencies. We’re being hoodwinked by…
NEWS ON THE FIGHT TO END HIV/AIDS, VIRAL HEPATITIS, AND TUBERCULOSIS Spring 2014 The April Fools' Issue: April 1. This is the day upon which we are reminded of what we are on the other three hundred and sixty-four. —Mark…
The science of discovery comes with ethical challenges in human clinical trials By Richard Jefferys Over the past several years, there has been a welcome invigoration of the research effort to cure HIV infection. The mainstream media has picked up…
By Tim Horn Though the number of new HIV infections in the United States is down from its peak in the 1980s, incidence has refused to budge below its decade-long average: roughly 50,000 American residents are infected with the virus…